Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-03-24

Clinical Trial Update: Intranasal Dexmedetomidine Versus Oral Midazolam as Premedication for Propofol Sedation in Pediatric Patients Undergoing Magnetic Resonance Imaging [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial comparing intranasal dexmedetomidine with oral midazolam as premedication for propofol sedation in pediatric MRI patients; current stat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PROPOFOL (Propofol)
  • intranasal Dexmedetomidine (dexmedetomidine)
  • oral midazolam (midazolam)

Snippet

Sponsor: Brugmann University Hospital | Conditions: MRI, Pediatric Sedation | Phase 3 | Status: UNKNOWN